Cost-Effectiveness of Routine Follow-up Visits in Patients With a Pacemaker: The Followpace Study

NCT00135174 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1526

Last updated 2008-06-17

No results posted yet for this study

Summary

The overall objective of the study is to quantify the true prognostic value and cost-effectiveness of routine follow-up visits in patients who receive an approved pacemaker of any type for the first time.

Conditions

Sponsors & Collaborators

  • College of Health Insurers/Society of Academic Hospitals,

    collaborator UNKNOWN
  • Dutch Working Group on Cardiac Pacing,

    collaborator UNKNOWN
  • Foundation Pacemaker Registry in The Netherlands,

    collaborator UNKNOWN
  • UMC Utrecht

    lead OTHER

Principal Investigators

  • Norbert van Hemel, M.D. · University of Utrecht, Julius Center for Primary Care and Health Sciences

  • Karel G Moons, PhD · University of Utrecht, Julius Center for Primary Care and Health Sciences

  • Diederick E Grobbee, M.D. · University of Utrecht, Julius Center for Primary Care and Health Sciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-09-30
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00135174 on ClinicalTrials.gov